Heather Beckwith, MD

Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation

Heather Beckwith

Contact Info

Mailing Address:
Department of Hematology, Oncology and Transplantation
420 Delaware Street SE, MMC 480
Minneapolis, MN 55455

Administrative Assistant Name
Kristin Blomquist

Administrative Phone
612-625-8942

Administrative Email
krblomqu@umn.edu

Administrative Fax Number
612-625-6919

Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation


Medical Oncologist


Medical School, Medical College of Wisconsin, Milwaukee, WI

Residency, University of Minnesota, Minneapolis, MN

Fellowship, University of Minnesota, Minneapolis, MN

Summary

Dr. Heather Beckwith received her M.D. degree from the Medical College of Wisconsin (Milwaukee) in 2006. She did her residency in Internal Medicine at the University of Minnesota. During her residency she worked on research in the laboratory of Dr. Douglas Yee investigating the tyrosine kinase inhibitor properties of BMS 554417 on the insulin-like growth factor receptor using the breast cancer cell line MCF-7. Dr. Beckwith then was chosen for a fellowship in Hematology, Oncology and Transplantation at the University of Minnesota. She became an Assistant Professor of Medicine (Hematology, Oncology and Transplantation) at the University of Minnesota in 2012.

Professional Associations

  • Member, American Society of Clinical Oncology
  • Member, American Society of Hematology
  • Member, American Association of Cancer Research

Research

Research Summary/Interests

  • Researching the changes in gene signature that occur with growth factor stimulation of breast cancer
  • Study the role of growth factors on the development of hormone resistance in breast cancer

Publications

  • Beckwith Heather, Yee Douglas. Utilizing RNA-seq to define phytochemical induced alterations in insulin and IGF regulated transcriptomes. Methods in Pharmacology and Toxicology. 2014:189-204.
  • Beckwith Heather, Fettig-Anderson Lynsey, Yueh Nathan, Yee Douglas. Rapamycin and Dalotuzumab in combination inhibit parental and endocrine resistant breast cancer cells. Cancer Research. 2012 December 15;72(24). SABCS Abstract No. 1040. Dec. 4-8, 2012

Clinical

Clinics

Breast Center

Board Certifications

  • Internal Medicine

Clinical Interests

Breast cancer treatment and care